News | April 06, 2012

Positron Receives Nuclear Regulatory Commission Manufacturing and Distribution License

April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the company's radiopharmaceutical manufacturing facility in Crown Point, Ind.

Positron received its pharmacy license from the Indiana Board of Pharmacy in December 2011, which served as a precursor to the NRC amendment and recent approval, allowing Positron to manufacture and distribute radiochemicals and radiopharmaceuticals throughout the United States. The company is currently producing Indium 111 Oxyquinoline for customer evaluation and commercial sale, with plans to process additional radioisotopes for medical use.

"This NRC approval completes the mandatory requirements qualifying our Crown Point site as a fully licensed and operational radiochemical manufacturing facility," said Scott Stiffler, Positron vice president of pharmaceuticals. "The capabilities at the Crown Point facility will play a vital role in Positron's expansion into radiopharmaceutical and radiochemical production and further development of products relevant to our full solution strategy. We expect sales of Indium Oxyquinoline to commence in the coming quarter."

For more information: www.positron.com


Additional Content

News | PET Imaging

Nov. 17, 2025 — GE HealthCare has announced that Cardiovascular Associates of America (CVAUSA) plans to broaden its ...

Home November 17, 2025
Home
News | PET Imaging

Sept. 18, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology ...

Home September 22, 2025
Home
News | PET Imaging

Sept. 8, 2025 — GE HealthCare recently announced a Distribution and Services Agreement (DSA) with CardioNavix, a part of ...

Home September 08, 2025
Home
News | PET Imaging

July 21, 2025 — Long COVID patients with abnormal cardiopulmonary PET/MR findings may be more likely to develop heart ...

Home July 22, 2025
Home
News | PET Imaging

Feb. 25, 2025— GE HealthCare has delivered the first patient doses of Flyrcado (flurpiridaz F 18) injection, a unit dose ...

Home March 03, 2025
Home
Subscribe Now